Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Circulation: Arrhythmia and Electrophysiology · 2026
DOI: 10.1161/circep.126.015245 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2026. Verfasst von Adishwar Rao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Guthrie Robert Packer Hospital, Sayre, PA (A.R.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Left Atrial Appendage Closure, Anticoagulants, Stroke. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Left atrial appendage closure (LAAC) is an alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation, but randomized controlled trials have primarily focused on composite end points, potentially obscuring differences in individual clinical outcomes. We compared the efficacy and safety of LAAC versus OAC with an emphasis on individual clinical outcomes. METHODS: A systematic review and meta-analysis of randomized controlled trials comparing LAAC with OAC in adults with atrial fibrillation was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Databases were searched from January 2000 to March 2026. The primary efficacy end point was any stroke, and the primary safety end point was major bleeding. Risk ratios (RRs) with 95% CIs were pooled using a random-effects model. RESULTS: Six randomized controlled trials comprising 7004 patients (3681 LAAC; 3323 OAC) were included. LAAC was associated with a higher risk of ischemic stroke (RR, 1.41 [95% CI, 1.04–1.91]; P =0.03; 3.2% versus 2.1%), without a significant difference in any stroke (RR, 1.08 [95% CI, 0.82–1.42]; P =0.60) or the composite of stroke, systemic embolism, or death (RR, 0.99 [95% CI, 0.77–1.29]; P =0.96). Cardiovascular mortality (RR, 0.88; P =0.40) and all-cause mortality (RR, 0.92; P =0.36) were similar between groups. Major bleeding, including procedural events, did not differ significantly (RR, 0.93; P =0.40), although LAAC was associated with a significantly lower risk of nonprocedural major bleeding (RR, 0.57 [95% CI, 0.43–0.77]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Guthrie Robert Packer Hospital, Sayre, PA (A.R.).
- Division of Electrophysiology, Heart and Vascular Institute, Saint Francis Health System, Tulsa, OK (V.R.).
- Division of Cardiology, Cook County Health, Chicago, IL (M.M., A.V.).
- Department of Internal Medicine, University of Texas Health Science Center at Tyler (R.C.).
- Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, India (V.T.).
- Jagadguru Jayadeva Murugarajendra Medical College, Davanagere, India (N.N.).
ORCID-Profile: Adishwar Rao, Venkatesh Ravi, Mukunthan Murthi, Rahul Chikatimalla, Vennela Talla, Nihal Nagaraj, Gaurav Dhar, Aviral Vij
Zitieren
APA
Rao, A., Ravi, V., Murthi, M., Chikatimalla, R., Talla, V., Nagaraj, N., Dhar, G., Jolly, N., & Vij, A. (2026). Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.126.015245
Vancouver
Rao A, Ravi V, Murthi M, Chikatimalla R, Talla V, Nagaraj N, et al. Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circulation: Arrhythmia and Electrophysiology. 2026. doi:10.1161/circep.126.015245
BibTeX
@article{Rao2026,
author = {Rao, Adishwar and Ravi, Venkatesh and Murthi, Mukunthan and Chikatimalla, Rahul and Talla, Vennela and Nagaraj, Nihal and Dhar, Gaurav and Jolly, Neeraj and Vij, Aviral},
title = {Left Atrial Appendage Closure Versus Oral Anticoagulation in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
journal = {Circulation: Arrhythmia and Electrophysiology},
year = {2026},
doi = {10.1161/circep.126.015245}
}
EUVIMED